| http://dbpedia.org/ontology/abstract
|
NGD-4715 is a drug developed by , which ac … NGD-4715 is a drug developed by , which acts as a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal models it has anxiolytic, antidepressant, and anorectic effects, and it has successfully passed Phase I clinical trials in humans. Neurogen was acquired by Ligand Pharmaceuticals in August, 2009, and NGD-4715 was not listed among its key assets. All four laboratories were closed and sold, and no employees were retained. The structure of NGD-4715 has been confused with for example 1-(5-bromo-6-methoxypyridin-2-yl)-4-(3,4-dimethoxybenzyl)piperazine.n-2-yl)-4-(3,4-dimethoxybenzyl)piperazine.
|
| http://dbpedia.org/ontology/casNumber
|
873318-96-8
|
| http://dbpedia.org/ontology/inn
|
none
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/NGD-4715.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
23508254
|
| http://dbpedia.org/ontology/wikiPageLength
|
3525
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1073189972
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Pyridines +
, http://dbpedia.org/resource/Antidepressant +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Anxiolytics +
, http://dbpedia.org/resource/Melanin-concentrating_hormone_receptor_1 +
, http://dbpedia.org/resource/Category:Anorectics +
, http://dbpedia.org/resource/Animal_model +
, http://dbpedia.org/resource/Ligand_Pharmaceuticals +
, http://dbpedia.org/resource/Receptor_%28biochemistry%29 +
, http://dbpedia.org/resource/Neurogen +
, http://dbpedia.org/resource/Melanin_concentrating_hormone +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Antagonist_%28pharmacology%29 +
, http://dbpedia.org/resource/Anxiolytic +
, http://dbpedia.org/resource/Anorectic +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Category:Phenol_ethers +
|
| http://dbpedia.org/property/c
|
25
|
| http://dbpedia.org/property/casNumber
|
873318
|
| http://dbpedia.org/property/f
|
3
|
| http://dbpedia.org/property/h
|
30
|
| http://dbpedia.org/property/inn
|
none
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/smiles
|
[H][C@@]12CCC[C@@H]C1=CC=CC=C1C
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Anxiolytic-stub +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Phenol_ethers +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Anorectics +
, http://dbpedia.org/resource/Category:Anxiolytics +
, http://dbpedia.org/resource/Category:Pyridines +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/NGD-4715?oldid=1073189972&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/NGD-4715.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/NGD-4715 +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q63210360 +
, http://yago-knowledge.org/resource/NGD-4715 +
, http://sr.dbpedia.org/resource/NGD-4715 +
, https://global.dbpedia.org/id/7Rzzj +
, http://rdf.freebase.com/ns/m.06w453x +
, http://sh.dbpedia.org/resource/NGD-4715 +
, http://dbpedia.org/resource/NGD-4715 +
|
| rdf:type |
http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/DrugOfAbuse103248958 +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/WikicatPiperazines +
, http://dbpedia.org/class/yago/Piperazine103946814 +
, http://dbpedia.org/class/yago/Vermifuge104528630 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/PsychotropicAgent104017429 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Tranquilizer104470232 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/MinorTranquilizer103771443 +
, http://dbpedia.org/class/yago/WikicatAnxiolytics +
, http://dbpedia.org/class/yago/Sedative104166553 +
, http://dbpedia.org/class/yago/Sedative-hypnotic104166841 +
, http://dbpedia.org/class/yago/Antidepressant102718811 +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/WikicatAntidepressants +
|
| rdfs:comment |
NGD-4715 is a drug developed by , which ac … NGD-4715 is a drug developed by , which acts as a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal models it has anxiolytic, antidepressant, and anorectic effects, and it has successfully passed Phase I clinical trials in humans. Neurogen was acquired by Ligand Pharmaceuticals in August, 2009, and NGD-4715 was not listed among its key assets. All four laboratories were closed and sold, and no employees were retained. The structure of NGD-4715 has been confused with for example 1-(5-bromo-6-methoxypyridin-2-yl)-4-(3,4-dimethoxybenzyl)piperazine.n-2-yl)-4-(3,4-dimethoxybenzyl)piperazine.
|
| rdfs:label |
NGD-4715
|
